Overexpression of hsa-miR-132-5p in ovarian endometriotic stromal cells promoted acquisition of endometriotic phenotype

In: Journal of Endometriosis and Pelvic Pain Disorders · 2025 · vol. 17(4) , pp. 178–183 · doi:10.1177/22840265251340361 · W4410452121
article OA: green CC0
AI-generated summary by claude@2026-06, 2026-06-08

Overexpression of hsa-miR-132-5p in normal endometrial stromal cells promoted motility and viability while inhibiting apoptosis, indicating it contributes to endometriotic phenotype acquisition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective: The microRNA hsa-miR-132-5p is upregulated in endometriotic cyst stromal cells (ECSCs). We investigate how hsa-miR-132-5p affects the progression of endometriosis. Methods: Normal endometrial stromal cells (NESCs) that have been isolated from normal eutopic endometrium without endometriosis and ECSCs isolated ovarian endometriotic cysts were assayed. We then evaluated how hsa-miR-132-5p impacted apoptosis, motility, and cell viability in hsa-miR-132-5p-transfected NESCs. Results: Transfection with hsa-miR-132-5p promoted cell motility and viability and inhibited the apoptosis of NESCs. Conclusions: Our results indicate that the expression of hsa-miR-132-5p promotes the acquisition of endometriosis-specific features during the progression of endometriosis. Thus, hsa-miR-132-5p may have potential value in the treatment of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK